Literature DB >> 16484826

Granulomatous dermatitis with enlarged histiocytes: a characteristic pattern of granulocyte colony-stimulating factor. Report of two cases and review of the literature.

Marta Ferran1, Fernando Gallardo, Antonio Salar, Mar Iglesias, Carlos Barranco, Ramon M Pujol.   

Abstract

Two patients developed a pruritic maculopapular rash following treatment with granulocyte colony-stimulating factor (G-CSF). Histopathological examination disclosed a superficial dermal inflammatory infiltrate composed of interstitially arranged large histiocytic CD68+ cells and perivascularly disposed lymphocytes. Large histiocytes were interspersed among the collagen bundles with associated slight deposits of mucin. Elastophagocytosis was occasionally observed, and a slight reduction of dermal elastic fibers was also noted. There was no evidence of frank granuloma formation, fibrosis or significant changes of collagen bundles. This histopathological variant of granulomatous dermatitis with "enlarged histiocytes" seems to be characteristic of an unusual cutaneous reaction secondary to CSF treatment. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16484826     DOI: 10.1159/000090660

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  3 in total

1.  Granulomatous Cutaneous Drug Eruptions: A Systematic Review.

Authors:  Nidhi Shah; Monica Shah; Aaron M Drucker; Neil H Shear; Michael Ziv; Roni P Dodiuk-Gad
Journal:  Am J Clin Dermatol       Date:  2021-01       Impact factor: 7.403

2.  Transient thrombocytopenia in a cat following G-CSF treatment.

Authors:  Kyeong-Bo Kim; Ju-Hyun An; Jeong-Hwa Lee; Su-Min Park; Hyung Kyu Chae; Woo-Jin Song; Hwa-Young Youn
Journal:  Vet Med Sci       Date:  2021-12-29

3.  Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Induced Severe Atypical Rash in a Patient of Non-Hodgkin's Lymphoma.

Authors:  Gautam Kumar Singh; Anuj Bhatnagar; Debdeep Mitra; Pooja Sharma; Abhay Singh; Barnali Mitra
Journal:  Indian J Dermatol       Date:  2022 Mar-Apr       Impact factor: 1.757

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.